Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting

• Status: Completed
• Trial end date: 2011-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this research study is to evaluate the drug gabapentin (Neurontin®) for its ability to reduce postoperative pain, the need for morphine-like pain medication, and the severity and frequency of postoperative nausea and vomiting in laparoscopic gastric bypass surgery patients.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical University of South Carolina
• Treatments: Gabapentin; gamma-Aminobutyric Acid

Criteria

Inclusion Criteria:

• Patients undergoing laparoscopic gastric bypass surgery

• Age > 18 years

Exclusion Criteria:

• Patients under the age of 18 years

• Patients who undergo open gastric bypass

• Patients with a history of chronic pain treated with pregabalin, gabapentin or opioids

• Patients with a history of chronic renal disease (creatinine > 1.3)

• Patients with a history of bleeding gastric ulcer